Oz Healthcare Communications appointed by Novartis 12 Feb 200812 Feb 2008 PrintPDFSend to a friendMore sharing options More sharing options Oz Healthcare Communications have added another account to their portfolio of global pharmaceutical brands with the addition of Aclasta (zoledronic acid) from Novartis.